RAMITENS 10

Valsts: Izraēla

Valoda: angļu

Klimata pārmaiņas: Ministry of Health

Nopērc to tagad

Aktīvā sastāvdaļa:

RAMIPRIL

Pieejams no:

RAFA LABORATORIES LTD

ATĶ kods:

C09AA05

Zāļu forma:

CAPSULES

Kompozīcija:

RAMIPRIL 10 MG

Ievadīšanas:

PER OS

Receptes veids:

Required

Ražojis:

RAFA LABORATORIES LTD, JERUSALEM

Ārstniecības grupa:

RAMIPRIL

Ārstniecības joma:

RAMIPRIL

Ārstēšanas norādes:

Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : - hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) - high total cholesterol (>5.2 mmol/L) - low HDL ( <0.9 mmol/L) - current smoker - known microalbuminuria - clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1g/day.

Autorizācija datums:

2014-08-31

Lietošanas instrukcija

                                1
PATIENT LEAFLET ACCORDING TO THE PHARMACISTS' REGULATIONS
(PREPARATIONS) –
1986
This medicine is sold with a doctor's prescription only
RAMITENS 10
CAPSULES
ACTIVE INGREDIENT:
Each Ramitens 10 capsule contains: Ramipril 10 mg
Inactive ingredients - see section 6. See also 'Important information
about some of
the medicine's ingredients' in section 2.
READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet contains
concise information about the medicine. If you have any further
questions, please
refer to your doctor or pharmacist.
This medicine has been prescribed for treatment for you. Do not pass
it on to others.
It may harm them, even if you think their medical condition is similar
to yours.
1. WHAT IS THE MEDICINE INTENDED FOR?
The medicine is used to treat hypertension, to reduce the risk of
having a heart attack
or stroke, to reduce the risk or to delay the worsening of kidney
problems (in diabetic
or nondiabetic patients), to treat heart failure, as treatment
following a heart attack
complicated with heart failure.
THERAPEUTIC GROUP: Antihypertensive, belongs to the ACE inhibitors
group.
2. BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:
−
You are sensitive (allergic) to the active ingredient ramipril or to
any other
preparation from the ACE inhibitors group, or to any of the other
ingredients the
medicine contains (see section 6). Signs of an allergic reaction may
include: rash,
swallowing or breathing difficulties, swelling of the lips, face,
throat or tongue.
−
You suffered in the past from a serious allergic reaction called
angioedema, whose
signs include: itching, hives (urticaria), red marks on the hands,
feet and throat,
swelling of the throat and tongue, swelling around the eyes and lips,
breathing and
swallowing difficulties.
−
You have taken or are currently taking sacubitril/valsartan, a
medicine used to treat
a type of chronic heart failure in adults.
−
You are undergoing dialysis or any other type of blood filtration.
Depending on the
type of machine in use, 
                                
                                Izlasiet visu dokumentu
                                
                            

Dokumenti citās valodās

Lietošanas instrukcija Lietošanas instrukcija arābu 05-08-2020
Lietošanas instrukcija Lietošanas instrukcija ivrits 07-09-2023

Meklēt brīdinājumus, kas saistīti ar šo produktu

Skatīt dokumentu vēsturi